Molekulare und zelluläre Grundlagen der Gelenkdestruktion bei rheumatoider Arthritis

Schlüsselwörter

Rheumatoide Arthritis - Gelenkdestruktion - Fibroblasten - Zytokine

Key words

rheumatoid arthritis - joint destruction - fibroblasts - cytokines

Literatur

• 1 Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity.  Nat Immunol. 2001;  2 675-680
• 2 Apparailly F, Bouquet C, Millet V. et al . Adenovirus-mediated gene transfer of urokinase plasminogen inhibitor inhibits angiogenesis in experimental arthritis.  Gene Ther. 2002;  9 192-200
• 3 Ballara S, Taylor P C, Reusch P. et al . Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.  Arthritis Rheum. 2001;  44 2055-2064
• 4 Blander J M, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells.  Nature. 2006;  440 808-812
• 5 Brentano F, Schorr O, Gay R E, Gay S, Kyburz D. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3.  Arthritis Rheum. 2005;  52 2656-2665
• 6 D’Acquisto F, Iuvone T, Rombola L, Sautebin L, Di Rosa M, Carnuccio R. Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages.  FEBS Lett. 1997;  418 175-178
• 7 Demasi M, Cleland L G, Cook-Johnson R J, James M J. Effects of hypoxia on the expression and activity of cyclooxygenase 2 in fibroblast-like synoviocytes: interactions with monocyte-derived soluble mediators.  Arthritis Rheum. 2004;  50 2441-2449
• 8 Distler J H, Jungel A, Huber L C. et al . The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles.  Proc Natl Acad Sci U S A. 2005;  102 2892-2897
• 9 Distler J H, Wenger R H, Gassmann M. et al . Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis.  Arthritis Rheum. 2004;  50 10-23
• 10 Edwards J C, Szczepanski L, Szechinski J. et al . Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.  N Engl J Med. 2004;  350 2572-2581
• 11 Fahmi H. mPGES-1 as a novel target for arthritis.  Curr Opin Rheumatol. 2004;  16 623-627
• 12 Fassbender H G, Simmling-Annefeld M. The potential aggressiveness of synovial tissue in rheumatoid arthritis.  J Pathol. 1983;  139 399-406
• 13 Feldmann M, Maini R N. The role of cytokines in the pathogenesis of rheumatoid arthritis.  Rheumatology (Oxford). 1999;  (Suppl 2) 38 3-7
• 14 Firestein G S, Echeverri F, Yeo M, Zvaifler N J, Green D R. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium.  Proc Natl Acad Sci U S A. 1997;  94 10895-10900
• 15 Franz J K, Pap T, Hummel K M. et al . Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis.  Arthritis Rheum. 2000;  43 599-607
• 16 Genovese M C, Bathon J M, Martin R W. et al . Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.  Arthritis Rheum. 2002;  46 1443-1450
• 17 Georganas C, Liu H, Perlman H, Hoffmann A, Thimmapaya B, Pope R M. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun.  J Immunol. 2000;  165 7199-7206
• 18 Giannelli G, Erriquez R, Iannone F, Marinosci F, Lapadula G, Antonaci S. MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis.  Clin Exp Rheumatol. 2004;  22 335-338
• 19 Giatromanolaki A, Sivridis E, Maltezos E. et al . Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis.  Arthritis Res Ther. 2003;  5 R193-201
• 20 Hitchon C, Wong K, Ma G, Reed J, Lyttle D, El-Gabalawy H. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts.  Arthritis Rheum. 2002;  46 2587-2597
• 21 Keyszer G M, Heer A H, Kriegsmann J. et al . Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization.  Arthritis Rheum. 1995;  38 976-984
• 22 Kinne R W, Boehm S, Iftner T. et al . Synovial fibroblast-like cells strongly express jun-B and C-fos proto-oncogenes in rheumatoid- and osteoarthritis.  Scand J Rheumatol Suppl. 1995;  101 121-125
• 23 Konttinen Y T, Ainola M, Valleala H. et al . Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis.  Ann Rheum Dis. 1999;  58 691-697
• 24 Kremer J M, Westhovens R, Leon M. et al . Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig.  N Engl J Med. 2003;  349 1907-1915
• 25 Kuchen S, Seemayer C A, Rethage J. et al . The L1 retroelement-related p40 protein induces p38delta MAP kinase.  Autoimmunity. 2004;  37 57-65
• 26 Kullmann F, Judex M, Neudecker I. et al . Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts.  Arthritis Rheum. 1999;  42 1594-1600
• 27 Kurowska-Stolarska M, Distler J H, Pap T. et al . The inhibitor of differentiation-2 (Id-2) induced by hypoxia promotes bone degradation in rheumatoid arthritis (RA).  Arthritis Rheum. 2004;  50 S655
• 28 Maini R, St C lair EW, Breedveld F. et al. ATTRACT Study Group . Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial.  Lancet. 1999;  354 1932-1939
• 29 Majumdar M, Tarui T, Shi B, Akakura N, Ruf W, Takada Y. Plasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha(9)beta(1).  J Biol Chem. 2004;  279 37528-37534
• 30 Miagkov A V, Kovalenko D V, Brown C E. et al . NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint.  Proc Natl Acad Sci U S A. 1998;  95 13859-13864
• 31 Moreland L W, Pratt P W, Mayes M D. et al . Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate.  Arthritis Rheum. 1995;  38 1581-1588
• 32 Müller-Ladner U, Gay R E, Gay S. Retroviral sequences in rheumatoid arthritis synovium.  Int Rev Immunol. 1998;  17 273-290
• 33 Müller-Ladner U, Kriegsmann J, Franklin B N. et al . Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice.  Am J Pathol. 1996;  149 1607-1615
• 34 Neidhart M, Rethage J, Kuchen S. et al . Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression.  Arthritis Rheum. 2000;  43 2634-2647
• 35 Neidhart M, Wehrli R, Bruhlmann P, Michel B A, Gay R E, Gay S. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis.  Arthritis Rheum. 1999;  42 622-630
• 36 Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.  J Immunol. 2000;  164 558-561
• 37 Ospelt C, Kuenzler P, Neidhart M. et al . p38delta induces MMP-3 expression in activated rheumatoid arthritis synovial fibroblasts.  Arthritis Rheum. 2004;  50 S155
• 38 Pages G, Pouyssegur J. Transcriptional regulation of the Vascular Endothelial Growth Factor gene - a concert of activating factors.  Cardiovasc Res. 2005;  65 564-573
• 39 Pap T, Aupperle K R, Gay S, Firestein G S, Gay R E. Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion.  Arthritis Rheum. 2001;  44 676-681
• 40 Pap T, Franz J K, Hummel K M, Jeisy E, Gay R, Gay S. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.  Arthritis Res. 2000;  2 59-64
• 41 Pap T, Nawrath M, Heinrich J. et al . Cooperation of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis.  Arthritis Rheum. 2004;  50 2794-2802
• 42 Pap T, Shigeyama Y, Kuchen S. et al . Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis.  Arthritis Rheum. 2000;  43 1226-1232
• 43 Pierer M, Muller-Ladner U, Pap T, Neidhart M, Gay R E, Gay S. The SCID mouse model: novel therapeutic targets - lessons from gene transfer.  Springer Semin Immunopathol. 2003;  25 65-78
• 44 Pierer M, Rethage J, Seibl R. et al . Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands.  J Immunol. 2004;  172 1256-1265
• 45 Raingeaud J, Gupta S, Rogers J S. et al . Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine.  J Biol Chem. 1995;  270 7420-7426
• 46 Ronday H K, Smits H H, Van Muijen G N. et al . Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.  Br J Rheumatol. 1996;  35 416-423
• 47 Rouse J, Cohen P, Trigon S. et al . A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins.  Cell. 1994;  78 1027-1037
• 48 Schedel J, Gay R E, Kuenzler P. et al . FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis.  Arthritis Rheum. 2002;  46 1512-1518
• 49 Schedel J, Seemayer C A, Pap T. et al . Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis.  Gene Ther. 2004;  11 1040-1047
• 50 Seibl R, Kyburz D, Lauener R P, Gay S. Pattern recognition receptors and their involvement in the pathogenesis of arthritis.  Curr Opin Rheumatol. 2004;  16 411-418
• 51 Sen M. Wnt signalling in rheumatoid arthritis.  Rheumatology (Oxford). 2005;  44 708-713
• 52 Sen M, Chamorro M, Reifert J, Corr M, Carson D A. Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation.  Arthritis Rheum. 2001;  44 772-781
• 53 Syrovets T, Jendrach M, Rohwedder A, Schule A, Simmet T. Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKKbeta-mediated NF-kappaB activation.  Blood. 2001;  97 3941-3950
• 54 Vabulas R M, Ahmad-Nejad P, Ghose S, Kirschning C J, Issels R D, Wagner H. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway.  J Biol Chem. 2002;  277 15107-15112
• 55 van der Laan W H, Pap T, Ronday H K. et al . Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor.  Arthritis Rheum. 2000;  43 1710-1718
• 56 van der Laan W H, Quax P H, Seemayer C A. et al . Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3.  Gene Ther. 2003;  10 234-242
• 57 Wakisaka S, Suzuki N, Saito N, Ochi T, Sakane T. Possible correction of abnormal rheumatoid arthritis synovial cell function by jun D transfection in vitro.  Arthritis Rheum. 1998;  41 470-481
• 58 Woessner J F. Matrix metalloproteinase inhibition: From the Jurassic to the third millennium.  Ann N Y Acad Sci. 1999;  878 388-403
• 59 Yamamoto A, Fukuda A, Seto H. et al . Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts.  Arthritis Rheum. 2003;  48 2682-2692
• 60 Yamanishi Y, Boyle D L, Pinkoski M J. et al . Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis.  Am J Pathol. 2002;  160 123-130
• 61 Yao Q, Wang S, Glorioso J C. et al . Gene transfer of p53 to arthritic joints stimulates synovial apoptosis and inhibits inflammation.  Mol Ther. 2001;  3 901-910
• 62 Zundel W, Schindler C, Haas-Kogan D. et al . Loss of PTEN facilitates HIF-1-mediated gene expression.  Genes Dev. 2000;  14 391-396